World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
26260
World Ranking
14622
National Ranking
7397

Overview

Paul Nghiem is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research spans multiple disciplines with a primary focus on medicine and engineering, contributing notably to oncology and electrical and electronic engineering subfields. Their work includes studies in aerospace engineering, plant science, and ecology, reflecting a diverse range of scientific interests.

Their research topics cover a broad spectrum including the study of polyomavirus and related diseases, antenna design and analysis, full-duplex wireless communications, plant virus research studies, bacteriophages and microbial interactions, cancer immunotherapy and biomarkers, and CAR-T cell therapy research.

Paul Nghiem has coauthored extensively with several researchers, frequently collaborating with Shailender Bhatia, Thomas H. Pulliam, Daniel S. Hippe, Kristina Lachance, and Candice D. Church. These collaborations represent some of the most consistent partnerships in their publication record.

They have contributed significantly to various academic journals and venues. Their most frequent outlets of publication include the Journal of Investigative Dermatology, Regular and Young Investigator Award Abstracts, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, and the Journal of the American Academy of Dermatology.

Recent publications highlight their work across dermatology, oncology, and biotechnology. Notable papers include:

  • Spatial transcriptomics at subspot resolution with BayesSpace, 2021, Nature Biotechnology
  • Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial, 2020, Journal of Clinical Oncology
  • Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial, 2020, Journal for ImmunoTherapy of Cancer
  • NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022, 2021, Journal of the National Comprehensive Cancer Network
  • First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study, 2021, Journal for ImmunoTherapy of Cancer

Best Publications

  • PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

    Paul T. Nghiem;Shailender Bhatia;Evan J. Lipson;Ragini R. Kudchadkar

  • Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

    Howard L. Kaufman;Jeffery Russell;Omid Hamid;Shailender Bhatia

  • Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features

    Michelle Heath;Natalia Jaimes;Bianca Lemos;Arash Mostaghimi

  • ATR Regulates Fragile Site Stability

    Anne M. Casper;Paul Nghiem;Paul Nghiem;Martin F. Arlt;Thomas W. Glover

  • Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system

    Bianca D. Lemos;Barry E. Storer;Jayasri G. Iyer;Jerri Linn Phillips

  • Merkel cell carcinoma.

    Jürgen C. Becker;Andreas Stang;James A. DeCaprio;Lorenzo Cerroni

  • Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System.

    Kelly L. Harms;Mark A. Healy;Paul Nghiem;Paul Nghiem;Paul Nghiem;Arthur J. Sober

  • Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics

    Kelly G. Paulson;Kelly G. Paulson;Song Youn Park;Natalie A. Vandeven;Kristina Lachance

  • Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature.

    Sheela G. Gupta;Linda C. Wang;Pablo F. Peñas;Martina Gellenthin

  • ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation

    Paul Nghiem;Peter K. Park;Yong Son Kim;Cyrus Vaziri

  • Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.

    Gerald Goh;Gerald Goh;Trent Walradt;Vladimir Markarov;Astrid Blom

  • Merkel Cell Polyomavirus Is More Frequently Present in North American than Australian Merkel Cell Carcinoma Tumors

    Kelly M. Garneski;Ashley H. Warcola;Qinghua Feng;Nancy B. Kiviat

  • Tacrolimus and pimecrolimus : From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis

    Paul Nghiem;Greg Pearson;Richard G. Langley

  • Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

    Paul Nghiem;Shailender Bhatia;Evan J. Lipson;William H. Sharfman

  • Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival

    Kelly G. Paulson;Jayasri G. Iyer;Andrew R. Tegeder;Renee Thibodeau

  • Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.

    Howard L. Kaufman;Jeffery S. Russell;Omid Hamid;Shailender Bhatia

  • Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

    Christopher K. Bichakjian;Thomas Olencki;Sumaira Z. Aasi;Murad Alam

  • Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma

    Joseph J. Carter;Kelly G. Paulson;Greg C. Wipf;Danielle Miranda

  • A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics

    Sharifeh Farasat;Siegrid S. Yu;Victor A. Neel;Kishwer S. Nehal

  • Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.

    Kelly G. Paulson;Joseph J. Carter;Lisa G. Johnson;Kevin W. Cahill

Frequent Co-Authors

Céleste Lebbé
Céleste Lebbé Hôpitaux Universitaires Paris-Ouest
Omid Hamid
Omid Hamid Cedars-Sinai Medical Center
Michele Milella
Michele Milella University of Verona
David M. Koelle
David M. Koelle University of Washington
Gerald P. Linette
Gerald P. Linette University of Pennsylvania
Howard L. Kaufman
Howard L. Kaufman Harvard University
Stuart L. Schreiber
Stuart L. Schreiber Harvard University
Denise A. Galloway
Denise A. Galloway Fred Hutchinson Cancer Research Center
Raphael Gottardo
Raphael Gottardo Fred Hutchinson Cancer Research Center
Ashok R. Shaha
Ashok R. Shaha Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but want to explore alternative routes or related fields, there are several flexible online degrees and programs that may suit your interests and goals.

Nursing continues to be a popular pathway, with many adn programs offering an accessible first step into healthcare. Some schools even admit students with fewer prerequisites, making it easier to start your journey.

For those interested in healthcare administration or medical office management, there are healthcare administration programs that can be completed online in less time than traditional degrees. These programs prepare you for leadership roles in clinics, hospitals, and other healthcare settings.

If you prefer a more administrative or technical health career, consider the best online medical billing and coding schools, which offer flexible study options and career-focused training.

Some nursing tracks may not require standardized tests for admission. For example, you can review schools that answer the question: do you have to take a teas test for lpn—a helpful resource for those seeking direct entry into practical nursing.

Best Scientists Citing Paul Nghiem

Trending Scientists